Posttransplantation estimated survival according to primary diagnosis and occurrence of grades II to IV, cortico-resistant AGvHD, or chronic GvHD. (A) The 10-year estimated survival of FA patients experiencing grades II to IV AGvHD was 38% (solid black line) versus 41% for non-FA patients (dashed gray line; P = NS). The 10-year estimated survival of FA patients who did not experience grades II to IV AGvHD was 92% (dashed black line) versus 69% for non-FA patients (solid gray line) (P = NS). (B) The 10-year estimated survival of FA patients experiencing cortico-resistant AGvHD was 37% (solid black line) versus 27% for non-FA patients (dashed gray line; P = NS). The 10-year estimated survival of FA patients who did not experience cortico-resistant AGvHD was 81% (dashed black line) versus 73% for non-FA patients (solid gray line; P = NS). (C) The 10-year estimated survival of patients experiencing chronic GvHD was 54% for FA patients (solid black line) and 65% for non-FA patients (solid gray line), respectively (P = NS). The 10-year estimated survival of FA patients who did not experience chronic GvHD was 86% (dashed black line) versus 59% for non-FA patients (dashed gray line; P = NS).